SignatureFD’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.98M Buy
21,548
+1,615
+8% +$141K 0.03% 262
2026
Q1
$1.7M Buy
19,933
+3,955
+25% +$352K 0.03% 272
2025
Q4
$1.26M Buy
15,978
+2,181
+16% +$171K 0.02% 317
2025
Q3
$1.1M Sell
13,797
-2,123
-13% -$181K 0.02% 360
2025
Q2
$1.45M Buy
15,920
+830
+6% +$75.8K 0.02% 270
2025
Q1
$1.41M Sell
15,090
-50
-0.3% -$4.48K 0.03% 257
2024
Q4
$1.38M Sell
15,140
-45
-0.3% -$4.29K 0.03% 243
2024
Q3
$1.58M Sell
15,185
-2,520
-14% -$257K 0.03% 218
2024
Q2
$1.72M Buy
17,705
+3,711
+27% +$342K 0.03% 185
2024
Q1
$1.26M Sell
13,994
-588
-4% -$49.8K 0.03% 256
2023
Q4
$1.16M Buy
14,582
+1,314
+10% +$98.8K 0.03% 249
2023
Q3
$943K Sell
13,268
-420
-3% -$31.4K 0.02% 265
2023
Q2
$1.05M Buy
13,688
+277
+2% +$21.4K 0.03% 238
2023
Q1
$1.01M Buy
13,411
+587
+5% +$43.6K 0.03% 238
2022
Q4
$1.01M Sell
12,824
-55
-0.4% -$4.12K 0.03% 231
2022
Q3
$905K Sell
12,879
-975
-7% -$76.5K 0.03% 215
2022
Q2
$1.11M Buy
13,854
+2,676
+24% +$209K 0.04% 171
2022
Q1
$848K Sell
11,178
-650
-5% -$51.5K 0.03% 250
2021
Q4
$1.01M Sell
11,828
-30
-0.3% -$2.34K 0.03% 212
2021
Q3
$896K Buy
11,858
+562
+5% +$44.6K 0.03% 219
2021
Q2
$919K Buy
11,296
+361
+3% +$29.5K 0.04% 210
2021
Q1
$862K Buy
10,935
+472
+5% +$37K 0.04% 187
2020
Q4
$895K Buy
10,463
+478
+5% +$39.5K 0.04% 151
2020
Q3
$770K Buy
9,985
+128
+1% +$9.76K 0.04% 166
2020
Q2
$722K Buy
9,857
+470
+5% +$33.4K 0.04% 155
2020
Q1
$623K Buy
9,387
+1,071
+13% +$75.5K 0.05% 154
2019
Q4
$572K Sell
8,316
-275
-3% -$18.8K 0.04% 215
2019
Q3
$632K Sell
8,591
-216
-2% -$15.7K 0.05% 161
2019
Q2
$631K Buy
8,807
+61
+0.7% +$4.33K 0.05% 142
2019
Q1
$599K Sell
8,746
-137
-2% -$8.85K 0.05% 149
2018
Q4
$529K Buy
8,883
+282
+3% +$17.6K 0.05% 164
2018
Q3
$576K Sell
8,601
-60
-0.7% -$4K 0.06% 170
2018
Q2
$561K Sell
8,661
-138
-2% -$9.03K 0.06% 156
2018
Q1
$631K Sell
8,799
-159
-2% -$11.4K 0.07% 110
2017
Q4
$676K Sell
8,958
-184
-2% -$13.4K 0.08% 106
2017
Q3
$666K Buy
9,142
+355
+4% +$25.6K 0.09% 92
2017
Q2
$651K Sell
8,787
-2,890
-25% -$215K 0.09% 86
2017
Q1
$855K Buy
11,677
+7,802
+201% +$546K 0.13% 58
2016
Q4
$254K Sell
3,875
-479
-11% -$32.8K 0.04% 178
2016
Q3
$323K Buy
4,354
+1,164
+36% +$86K 0.05% 153
2016
Q2
$234K Buy
3,190
+146
+5% +$10.4K 0.03% 161
2016
Q1
$215K Buy
3,044
+252
+9% +$16.8K 0.04% 159
2015
Q4
$186K Buy
2,792
+575
+26% +$38.3K 0.04% 146
2015
Q3
$141K Buy
2,217
+357
+19% +$23.3K 0.03% 167
2015
Q2
$122K Buy
1,860
+499
+37% +$33.9K 0.03% 194
2015
Q1
$94K Buy
1,361
+58
+4% +$4.01K 0.02% 218
2014
Q4
$90K Buy
1,303
+73
+6% +$4.93K 0.02% 212
2014
Q3
$80K Hold
1,230
0.03% 203
2014
Q2
$84K Hold
1,230
0.03% 192
2014
Q1
$80K Sell
1,230
-1,025
-45% -$64.6K 0.03% 138
2013
Q4
$147K Buy
2,255
+160
+8% +$10.2K 0.05% 107
2013
Q3
$124K Buy
2,095
+800
+62% +$47.4K 0.05% 109
2013
Q2
$74K Buy
+1,295
New +$76.9K 0.04% 137

Other funds holding CL

SignatureFD's CL Position: Q2 2026 in Review

SignatureFD increased its Colgate-Palmolive (CL) stake by 8.1% in Q2 2026, buying an estimated $141K and bringing the position to 21,548 shares worth $1.98M. The position accounts for 0.03% of the portfolio, ranked #262.

SignatureFD first reported a position in CL in Q2 2013 and has held it in 53 quarters since. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • SignatureFD held 21,548 shares of Colgate-Palmolive worth $1.98M as of Q2 2026.
  • SignatureFD bought 1,615 Colgate-Palmolive shares in Q2 2026, an estimated $141K.
  • Colgate-Palmolive made up 0.03% of SignatureFD's portfolio in Q2 2026, its #262 holding.
  • SignatureFD first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.